The DOI matches its Crossref record.
Specification of the Neurobehavioral Phenotype in Males with Fragile X Syndrome
Abstract
Objective. A controlled clinical study was designed to identify the neurobehavioral profile that is specific to males with fragile X syndrome. Design. Thirty-one males with fragile X syndrome and 30 age and IQ-matched male controls were evaluated with instruments that assess multiple domains of adaptive functioning and problem behaviors. The Vineland Adaptive Behavior Scales and the Aberrant Behavior Checklist were selected for their dimensional scaling of behavioral ratings. Results. Parent and Teacher versions of the Aberrant Behavior Checklist demonstrated a profile of behaviors specific to males with fragile X syndrome characterized by significantly higher levels of hyperactivity, stereotypic movements, and unusual speech. The Vineland Adaptive Behavior Scales revealed no fragile X-specific profile of adaptive skills development. Conclusions. The distinct pattern of aberrant behaviors observed among males with fragile X emphasizes the importance of drawing subtype distinctions within the classification of individuals with mental retardation on the basis of underlying etiology. For clinical research, specifying the fragile X phenotype is a vital part in the effort to elucidate the neurodevelopmental pathways of normal behavior and psychopathology. Understanding the fragile X symptom pattern is essential for designing symptom-specific treatment interventions, as well as for research into the efficacy of interventions strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Hagerman, R. J., Berry-Kravis, E., Hazlett, H. C., Bailey, D. B., Moine, H., Kooy, R. F., Tassone, F., Gantois, I., Sonenberg, N., Mandel, J. L., et al. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.65 · Cited by 838
Advances in the Treatment of Fragile X Syndrome
Hagerman, R. J., Berry-Kravis, E., Kaufmann, W. E., Ono, M. Y., Tartaglia, N., Lachiewicz, A., Kronk, R., Delahunty, C., Hessl, D., Visootsak, J., et al. (2009) · Pediatrics · doi:10.1542/peds.2008-0317 · Cited by 596
ROGERS, S. J., WEHNER, E. A., & HAGERMAN, R. (2001) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/00004703-200112000-00008 · Cited by 488
Therapeutic potential of mood stabilizers lithium and valproic acid:Beyond bipolar disorder
Chiu, C.-T., Wang, Z., Hunsberger, J. G., & Chuang, D.-M. (2013) · Pharmacological Reviews · doi:10.1124/pr.111.005512 · Cited by 404
Kaufmann, W. E., Cortell, R., Kau, A. S. M., Bukelis, I., Tierney, E., Gray, R. M., Cox, C., Capone, G. T., & Stanard, P. (2004) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.30229 · Cited by 401
Autism Profiles of Males With Fragile X Syndrome
Harris, S. W., Hessl, D., Goodlin-Jones, B., Ferranti, J., Bacalman, S., Barbato, I., Tassone, F., Hagerman, P. J., Herman, K., & Hagerman, R. J. (2008) · American Journal on Mental Retardation · doi:10.1352/2008.113:427-438 · Cited by 396
Autism Spectrum Phenotype in Males and Females with Fragile X Full Mutation and Premutation
Clifford, S., Dissanayake, C., Bui, Q. M., Huggins, R., Taylor, A. K., & Loesch, D. Z. (2007) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-006-0205-z · Cited by 377
Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome
Berry-Kravis, E. M., Lindemann, L., Jønch, A. E., Apostol, G., Bear, M. F., Carpenter, R. L., Crawley, J. N., Curie, A., Des Portes, V., Hossain, F., et al. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.221 · Cited by 336
Deficits in trace fear memory and long-term potentiation in a mouse model for fragile X syndrome
Zhao, M.-G., Toyoda, H., Ko, S. W., Ding, H.-K., Wu, L.-J., & Zhuo, M. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1520-05.2005 · Cited by 296
Autistic behavior in young boys with fragile X syndrome
Bailey, D. B., Mesibov, G. B., Hatton, D. D., Clark, R. D., Roberts, J. E., & Mayhew, L. (1998) · Journal of Autism and Developmental Disorders · doi:10.1023/a:1026048027397 · Cited by 260
Paul, L. K. (2011) · Journal of Neurodevelopmental Disorders · doi:10.1007/s11689-010-9059-y · Cited by 260
Neurodevelopmental effects of the FMR-1 full mutation in humans
Reiss, A. L., Abrams, M. T., Greenlaw, R., Freund, L., & Denckla, M. B. (1995) · Nature Medicine · doi:10.1038/nm0295-159 · Cited by 242
Self-citationA phenotypic and molecular characterization of the fmr1‐tm1Cgr Fragile X mouse
Yan, Q. J., Asafo‐Adjei, P. K., Arnold, H. M., Brown, R. E., & Bauchwitz, R. P. (2004) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2004.00087.x · Cited by 213
Hessl, D., Dyer-Friedman, J., Glaser, B., Wisbeck, J., Barajas, R. G., Taylor, A., & Reiss, A. L. (2001) · Pediatrics · doi:10.1542/peds.108.5.e88 · Cited by 201
Self-citationAutism spectrum disorder in fragile X syndrome: a longitudinal evaluation
Hernandez, R. N., Feinberg, R. L., Vaurio, R., Passanante, N. M., Thompson, R. E., & Kaufmann, W. E. (2009) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.32848 · Cited by 178
Tracing syndrome-specific trajectories of attention across the lifespan.
CORNISH, K., SCERIF, G., & KARMILOFFSMITH, A. (2007) · Cortex · doi:10.1016/s0010-9452(08)70497-0 · Cited by 178
Fragile X: Leading the Way for Targeted Treatments in Autism
Wang, L. W., Berry-Kravis, E., & Hagerman, R. J. (2010) · Neurotherapeutics · doi:10.1016/j.nurt.2010.05.005 · Cited by 176
ADHD symptoms in children with FXS
Sullivan, K., Hatton, D., Hammer, J., Sideris, J., Hooper, S., Ornstein, P., & Bailey, D. (2006) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.31388 · Cited by 174
Min, W. W., Yuskaitis, C. J., Yan, Q., Sikorski, C., Chen, S., Jope, R. S., & Bauchwitz, R. P. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.09.017 · Cited by 146
The neurobiology of attention deficit/hyperactivity disorder
Curatolo, P., Paloscia, C., D'Agati, E., Moavero, R., & Pasini, A. (2009) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2008.06.003 · Cited by 136
Spatial cognition in males with Fragile-X syndrome: evidence for a neuropsychological phenotype
CORNISH, K., MUNIR, F., & CROSS, G. (1999) · Cortex · doi:10.1016/s0010-9452(08)70799-8 · Cited by 112
Therapeutic Strategies in Fragile X Syndrome: From Bench to Bedside and Back
Gross, C., Hoffmann, A., Bassell, G. J., & Berry-Kravis, E. M. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0355-9 · Cited by 105
“U P st at es Pr ol on ge d [9 7, 15 0] N o”
BackgroundInfluentialGenetic and Environmental Influences on the Cognitive Outcomes of Children With Fragile X Syndrome
DYER-FRIEDMAN, J., GLASER, B., HESSL, D., JOHNSTON, C., HUFFMAN, L. C., TAYLOR, A., WISBECK, J., & REISS, A. L. (2002) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200203000-00002 · Cited by 100
“, 1994); behavioral dysfunction such as hyperarousal, social anxiety, withdrawal, and attention problems (Baumgardner et al., 1995; Boccia and Roberts, 2000; Cohen, 1995; Freund et al., 1993); and subtle physical abnormalities including a long, narrow face, prominent ears, prominent forehead and jaw, and in males, mac…”
BackgroundSelf-citationTorrioli, M. G., Vernacotola, S., Peruzzi, L., Tabolacci, E., Mila, M., Militerni, R., Musumeci, S., Ramos, F. J., Frontera, M., Sorge, G., et al. (2008) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.32268 · Cited by 100
Gene, brain, and behavior relationships in fragile X syndrome: Evidence from neuroimaging studies
Lightbody, A. A., & Reiss, A. L. (2009) · Developmental Disabilities Research Reviews · doi:10.1002/ddrr.77 · Cited by 85
Self-citationTreatment with valproic acid ameliorates ADHD symptoms in fragile X syndrome boys
Torrioli, M., Vernacotola, S., Setini, C., Bevilacqua, F., Martinelli, D., Snape, M., Hutchison, J. A., Di Raimo, F. R., Tabolacci, E., & Neri, G. (2010) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33484 · Cited by 71
“%) of boys with FXS meet the diagnostic criteria for attention deficit hyperactivity disorder (ADHD) compared to 33% of their age and IQ-matched peers [Baumgardner et al., 1995].”
MethodThurman, A. J., McDuffie, A., Hagerman, R., & Abbeduto, L. (2014) · Research in Developmental Disabilities · doi:10.1016/j.ridd.2014.01.032 · Cited by 70
“…of males with FXS are likely to display some behaviors that are characteristically observed in individuals with nonsyndromic autism spectrum disorder (ASD), that is, individuals with ASD for whom there is no known etiology (Bailey et al., 2004; Baumgardner et al., 1995; Hartley et al., 2011).”
Screening for fragile X syndrome.
Murray, Cuckle, Taylor, & Hewison (1997) · Health Technology Assessment · doi:10.3310/hta1040 · Cited by 60
Blink rate in boys with fragile X syndrome: preliminary evidence for altered dopamine function
Roberts, J. E., Symons, F. J., Johnson, A. ‐., Hatton, D. D., & Boccia, M. L. (2005) · Journal of Intellectual Disability Research · doi:10.1111/j.1365-2788.2005.00713.x · Cited by 24
Metadata
- Authors
- Baumgardner, T. L., Reiss, A. L., Freund, L. S., & Abrams, M. T.
- Venue
- Pediatrics
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 1995-05-01
- Volume
- 95
- Issue
- 5
- Pages
- 744-752
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- OpenAlex
- W1840575452
- Cited by
- 246
- References
- 0
- FWCI
- 3.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.